New launch tracking reports and patient audit data show early excitement and ample opportunity for the latest approvals as well...
Authors: Meghan Staudt, Skylar Malone, Tucker Hurtado BACKGROUND: Disparities in kidney care are widespread and gaining more attention. This research...
Authors: Charisse Pearson Bey, Tucker Hurtado, and Jennifer Robinson BACKGROUND: The objective of this study was to evaluate the...
Authors: Meghan Staudt, Tucker Hurtado, Jennifer Robinson BACKGROUND: The purpose of this study was to understand the real-world patient...
Authors: Ryan Rex, Tucker Hurtado, and Jennifer Robinson BACKGROUND: Early uptake and experience with recently approved lupus nephritis (LN)...
Authors: Ryan Rex, Tucker Hurtado, and Jennifer Robinson BACKGROUND: One-half of nephrologists selected glomerular diseases as their leading area...
Authors: Meghan Staudt, Tucker Hurtado, and Jennifer Robinson BACKGROUND: This research examines the evolving care and treatment of patients...
Authors: Skylar Malone, Tucker Hurtado, and Jennifer Robinson BACKGROUND: Dialysis patients often suffer from some level of associated pruritus...
Independently funded research on glomerular diseases, lupus nephritis, SGLT2 inhibitors, disparities in care, HIF-PH inhibitors, CKD-associated pruritus, and COVID-19 impacts...
New research provides insight into unmet needs, current treatment paradigms, and nephrologists’ opinions on upcoming pipeline product potential across the...
From: FiercePharma By: Fraiser Kansteiner In the aftermath of a surprise FDA rejection in chronic kidney disease, Ardelyx is...
From: FiercePharma By: Beth Snyder Bulik Stunning reversals, surprise delays and controversial approvals are the order of the day...
